Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.54 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | HRH2 | P25021 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL427500 | 0.96 | TSHR (0.58) | TSHRDNM1ALDH1A1THRBPOLB | |
| Hydrochloric Acid SCHEMBL25265974 | 0.94 | TSHR (0.57) | TSHRDNM1ALDH1A1THRBPOLB | |
| Methacrylic Acid SCHEMBL4638039 | 0.91 | ALDH1A1 (0.50) | TSHRDNM1ALDH1A1THRBPOLB | |
| SCHEMBL9767545 | 0.90 | TSHR (0.69) | TSHRDNM1ALDH1A1THRBPOLB | |
| SCHEMBL3366486 | 0.90 | TSHR (0.69) | TSHRDNM1ALDH1A1THRBPOLB | |
| SCHEMBL8424369 | 0.90 | TSHR (0.66) | TSHRDNM1ALDH1A1THRBPOLB | |
| SCHEMBL1704602 | 0.90 | TSHR (0.66) | TSHRDNM1ALDH1A1THRBPOLB | |
| Methacrylic Acid SCHEMBL27388646 | 0.90 | TSHR (0.66) | TSHRALDH1A1THRBPOLBAPEX1 | |
| Methacrylic Acid SCHEMBL4865839 | 0.90 | TSHR (0.66) | TSHRALDH1A1THRBPOLBAPEX1 | |
| Cadaverine Tartrate SCHEMBL25213297 | 0.90 | TSHR (0.49) | TSHRDNM1ALDH1A1THRBPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4241758-A2 | ANTI-DANDRUFF COMPOSITION | L'OREAL (FR) | 2023-09-13 | — | — | EP | disclosed |
| EP-2934454-B1 | ANTI-DANDRUFF COMPOSITION | OREAL (FR) | 2023-07-12 | — | — | EP | disclosed |
| US-11000470-B2 | Methods, compositions, and kits for treating hair | L'OREAL (FR) | 2021-05-11 | — | — | US | disclosed |
| US-20190029948-A1 | METHODS, COMPOSITIONS, AND KITS FOR TREATING HAIR | L'OREAL (FR) | 2019-01-31 | — | — | US | disclosed |
| EP-2934454-A1 | ANTI-DANDRUFF COMPOSITION | L'Oréal (FR) | 2015-10-28 | — | — | EP | disclosed |
| US-8920787-B2 | Mascara containing an aqueous dispersion of polyurethane and an acrylic film former | L'OREAL (FR) | 2014-12-30 | — | — | US | disclosed |
| US-8846018-B2 | Mascara compositions containing at least two acrylate film formers | L'OREAL (FR) | 2014-09-30 | — | — | US | disclosed |
| WO-2014095625-A1 | ANTI-DANDRUFF COMPOSITION | L'OREAL (FR) | 2014-06-26 | — | — | WO | disclosed |
| US-8574561-B1 | Compositions containing anti-dandruff agents | L'OREAL (FR) | 2013-11-05 | — | — | US | disclosed |
| EP-2563326-A2 | MASCARA CONTAINING AN AQUEOUS DISPERSION OF POLYURETHANE AND AN ACRYLIC FILM FORMER | L'Oréal SA (FR) | 2013-03-06 | — | — | EP | disclosed |
| US-20130039874-A1 | MASCARA CONTAINING AN AQUEOUS DISPERSION OF POLYURETHANE AND AN ACRYLIC FILM FORMER | L'OREAL S.A. (FR) | 2013-02-14 | — | — | US | disclosed |
| US-20130028650-A1 | MASCARA COMPOSITIONS CONTAINING AT LEAST TWO ACRYLATE FILM FORMERS | L'OREAL (FR) | 2013-01-31 | — | — | US | disclosed |
| US-20110300092-A1 | MASCARAS OBTAINED VIA MULTI-PHASE PRODUCT | L'OREAL (FR) | 2011-12-08 | — | — | US | disclosed |
| WO-2011137338-A2 | MASCARA CONTAINING AN AQUEOUS DISPERSION OF POLYURETHANE AND AN ACRYLIC FILM FORMER | L'OREAL S.A. (FR) | 2011-11-03 | — | — | WO | disclosed |
| CN-101926743-A | Mineral-oil free, polymerically stabilized make-up remover | OREAL | 2010-12-29 | — | — | CN | disclosed |
| US-20100137179-A1 | Mineral oil free polymerically stabilized make-up remover | L'OREAL (FR) | 2010-06-03 | — | — | US | disclosed |
| EP-2181695-A2 | Mineral-oil free, polymerically stabilized make-up remover | L'Oreal (FR) | 2010-05-05 | — | — | EP | disclosed |
| US-20100028284-A1 | Mascara compositions containing at least two acrylate film formers | L'OREAL (FR) | 2010-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130039874-A1 | MASCARA CONTAINING AN AQUEOUS DISPERSION OF POLYURETHANE AND AN ACRYLIC FILM FORMER | ALG3, SMC3, MATR3 | TSHR 4810/4885DNM1 708/4885ALDH1A1 844/4885 |
| US-11000470-B2 | Methods, compositions, and kits for treating hair | CBL, FZD7, EZH2 | TSHR 2133/4885DNM1 4163/4885ALDH1A1 3915/4885 |
| US-20100137179-A1 | Mineral oil free polymerically stabilized make-up remover | DEGS1, CUTA, SMURF1 | TSHR 2164/4885DNM1 3021/4885ALDH1A1 4658/4885 |
| US-20110300092-A1 | MASCARAS OBTAINED VIA MULTI-PHASE PRODUCT | CUTA, AQP3, LSS | TSHR 3462/4885DNM1 2393/4885ALDH1A1 2122/4885 |
| US-20190029948-A1 | METHODS, COMPOSITIONS, AND KITS FOR TREATING HAIR | CBL, FZD7, EZH2 | TSHR 2133/4885DNM1 4163/4885ALDH1A1 3915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.